drugset

drugset / Trial / NCT03832049

HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial

NCT03832049 ↗

Phase 3 Unknown 1720 enrolled London School of Hygiene and Tropical Medicine Merck Sharp & Dohme LLC · collab Public Health England · collab University of Cambridge · collab

RandomizedParallel-groupSingle-blindPrevention

Summary

A randomized, observer-blind non-inferiority trial to evaluate alternative human papillomavirus (HPV) vaccination schedules in young females in West Africa.

Timeline

Start: 2019-09-14
Primary completion: 2024-06
Completion: 2024-06

Publications

Bergman H, Henschke N, Arevalo-Rodriguez I, Buckley BS, Crosbie EJ, Davies JC, Dwan K, Golder SP, Loke YK, Probyn K, Petkovic J, Villanueva G, Morrison J. Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis. Cochrane Database Syst Rev. 2025 Nov 24;11(11):CD015364. doi: 10.1002/14651858.CD015364.pub2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Gardasil 9	Vaccine	0.5 ml	Intramuscular

Indications

No indication recorded.